Osteoporosis screening of postmenopausal women in the primary care setting: A case-based approach

Gender Medicine

Volumn 1, Issue 2, 2004, Pages 70-85

  Edwards, Beatrice J ^a   Brooks, Ellen R ^a   Langman, Craig B ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

Author keywords

BMD; Bone health; Bone mass; DXA; Osteoporosis; Screening; Women's health

Indexed keywords

ALENDRONIC ACID; BISPHOSPHONIC ACID DERIVATIVE; CALCITONIN; CALCIUM; ESTROGEN; GESTAGEN; PARATHYROID HORMONE[1-34]; RALOXIFENE; RISEDRONIC ACID; SELECTIVE ESTROGEN RECEPTOR MODULATOR; VITAMIN D;

BONE DENSITY; CALCIUM INTAKE; FEMALE; FRAGILITY FRACTURE; HUMAN; MEDLINE; MORBIDITY; MORTALITY; PATHOPHYSIOLOGY; POSTMENOPAUSE OSTEOPOROSIS; PRACTICE GUIDELINE; PREVALENCE; PRIMARY MEDICAL CARE; PRIMARY PREVENTION; PRIORITY JOURNAL; REVIEW; RISK ASSESSMENT; SCREENING TEST;

ADULT; BONE DENSITY; DENSITOMETRY, X-RAY; FEMALE; FRACTURES, BONE; HUMANS; INCIDENCE; MASS SCREENING; MIDDLE AGED; OSTEOPOROSIS, POSTMENOPAUSAL; PHYSICIAN'S PRACTICE PATTERNS; PRIMARY HEALTH CARE; PRIMARY PREVENTION; RISK ASSESSMENT;

EID: 14644406852     PISSN: 15508579     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1550-8579(04)80013-5     Document Type: Review

References (84)

1. NIH Consensus Development Panel on Osteoporosis Prevention, Diagnosis and Therapy JAMA 285 2001 785-795
2. Melton LJ III Chrischilles EA Cooper C et al. Perspective. How many women have osteoporosis? J Bone Miner Res 7 1992 1005-1010
3. Keene GS Parker MJ Pryor GA Mortality and morbidity after hip fractures BMJ 307 1993 1248-1250
4. Palmer RM Saywell RM Jr Zollinger TW et al. The impact of prospective payment system on the treatment of hip fractures in the elderly Arch Intern Med 149 1989 2237-2241
5. Cooper C Atkinson EJ O'Fallon WM Melton LJ III Incidence of clinically diagnosed vertebral fractures: A population-based study in Rochester, Minnesota, 1985-1989 J Bone Miner Res 7 1992 221-227
6. Cauley JA Thompson DE Ensrud KC et al. Risk of mortality following clinical fractures Osteoporos Int 11 2000 556-561
7. Kado DM Browner WS Palermo L et al. for the Study of Osteoporotic Fractures Research Group Vertebral fractures and mortality in older women: A prospective study Arch Intern Med 159 1999 1215-1220
8. Understanding Osteoporosis: A Survey of American Women 1991 National Osteoporosis Foundation Bethesda, Md
9. Nelson HD Helfand M Woolf SH Allan JD Screening for postmenopausal osteoporosis: A review of the evidence for the US Preventive Services Task Force Ann Intern Med 137 2002 529-541
10. Meyer HE Tverdal A Falch JA Risk factors for hip fracture in middle-aged Norwegian women and men Am J Epidemiol 137 1993 1203-1211
11. Siris ES Miller PD Barrett-Connor E et al. Identification and fracture outcomes of undiagnosed low bone mineral density in post-menopausal women: Results from the National Osteoporosis Risk Assessment JAMA 286 2001 2815-2822
12. Tuppurainen M Kroger H Honkanen R et al. Risks of perimenopausal fractures - a prospective population-based study Acta Obstet Gynecol Scand 74 1995 624-628
13. Cummings SR Nevitt MC Browner WS et al. for the Study of Osteoporotic Fractures Research Group Risk factors for hip fractures in white women N Engl J Med 332 1995 763-773
14. Cummings SR Treatable and untreatable risk factors for hip fracture Bone 18 Suppl 3 1996 165S-167S
15. Fox KM Cummings SR Powell-Threets K Stone K for the Study of Osteoporotic Fractures Research Group Family history and risk of osteoporotic fracture Osteoporos Int 8 1998 557-562
16. Ensrud KE Palermo L Black DM et al. Hip and calcaneal bone loss increase with advancing age: Longitudinal results from the Study of Osteoporotic Fractures J Bone Miner Res 10 1995 1778-1787
17. Vogt MT Cauley JA Scott JC et al. Smoking and mortality among older women: The Study of Osteoporotic Fractures Arch Intern Med 156 1996 630-636
18. Ensrud KE Lipschutz RC Cauley JA et al. for the Study of Osteoporotic Fractures Research Group Body size and hip fracture risk in older women: A prospective study Am J Med 103 1997 274-280
19. Gregg EW Cauley JA Seeley DG et al. for the Study of Osteoporotic Fractures Research Group Physical activity and osteoporotic fracture risk in older women Ann Intern Med 129 1998 81-88
20. Physician's Guide to Prevention and Treatment of Osteoporosis 2003 National Osteoporosis Foundation Washington, DC
21. Hodgson SF Watts NB Bilezikian JP et al. for the American Association of Clinical Endocrinologists Medical guidelines for clinical practice for the prevention and management of post-menopausal osteoporosis Endocr Pract 7 2001 293-313
22. Writing Group for the International Society for Clinical Densitometry (ISCD) Position Development Conference Position statement: Executive summary J Clin Densitom 7 2004 7-12
23. Rimes KA Salkovskis PM Shipman AJ Psychological and behavioural effects of bone density screening for osteoporosis Psychol Health 14 1999 585-608
24. Lydick E Cook K Turnpin J et al. Development and validation of a simple questionnaire to facilitate identification of women likely to have low bone density Am J Manag Care 4 1998 37-48
25. Cadarette SM Jaglal SB Kreiger N et al. Development and validation of the Osteoporosis Risk Assessment Instrument to facilitate selection of women for bone densitometry CMAJ 162 2000 1289-1294
26. Cadarette SM Jaglal SB Murray TM et al. Evaluation of decision rules for referring women for bone densitometry by dual-energy x-ray absorptiometry JAMA 286 2001 57-63
27. Reginster JY Ben Sedrine W Viethel P et al. Validation of OSIRIS, a prescreening tool for the identification of women with an increased risk of osteoporosis Gynecol Endocrinol 18 2004 3-8
28. Lyles KW Gold DT Shipp KM et al. Association of osteoporotic vertebral compression fractures with impaired functional status Am J Med 94 1993 595-601
29. Abrahamsen B Bonnevie-Nielsen V Ebbesen EN Cytokines and bone loss in a 5-year longitudinal study - hormone replacement therapy suppresses serum soluble interleukin-6 receptor and increases interleukin-1-receptor antagonist: The Danish Osteoporosis Prevention Study J Bone Miner Res 15 2000 1545-1554
30. Nordin BE Need AG Chatterton BE et al. The relative contributions of age and years since menopause to postmenopausal bone loss J Clin Endocrinol Metab 70 1990 83-88
31. Chapurlat RD Gamero P Sornay-Rendu E et al. Longitudinal study of bone loss in pre- and perimenopausal women: Evidence for bone loss in perimenopausal women Osteoporos Int 11 2000 493-498
32. Wu F Mason B Horne A et al. Fractures between the ages of 20 and 50 years increase women's risk of subsequent fractures Arch Intern Med 162 2002 33-36
33. Mallmin H Ljunghall S Persson I et al. Fracture of the distal forearm as a forecaster of subsequent hip fracture: A population-based cohort study with 24 years of follow-up Calcif Tissue Int 52 1993 269-272
34. Cuddihy MT Gabriel SE Crowson CS et al. Forearm fractures as predictors of subsequent osteoporotic fractures Osteoporos Int 9 1999 469-475
35. Nilsson BE Westlin NE Long-term observations on the loss of bone mineral following Colles' fracture Acta Orthop Scand 46 1975 61-66
36. Finsen V Benum P Osteopenia after ankle fractures Clin Orthop 245 1989 261-268
37. Hajcsar EE Hawker G Bogoch ER Investigation and treatment of osteoporosis in patients with fragility fractures CMAJ 163 2000 819-822
38. Castel H Bonneh DY Sherf M Liel Y Awareness of osteoporosis and compliance with management guidelines in patients with newly diagnosed low-impact fractures Osteoporos Int 12 2001 559-564
39. The Writing Group for the PEPI Effects of hormone therapy on bone mineral density: Results from the Postmenopausal Estrogen/Progestin Interventions (PEPI) trial JAMA 276 1996 1389-1396
40. Johnston CC Jr Bjarnason NH Cohen FJ et al. Long-term effects of raloxifene on bone mineral density, bone turnover, and serum lipid levels in early postmenopausal women: Three-year data from 2 double-blind, randomized, placebo-controlled trials Arch Intern Med 160 2000 3444-3450
41. Ravn P Weiss SR Rodriguez-Portales JA et al. for the Alendronate Osteoporosis Prevention Study Group Alendronate in early postmenopausal women: Effects on bone mass during long-term treatment and after withdrawal J Clin Endocrinol Metab 85 2000 1492-1497
42. Mortensen L Charles P Bekker PJ et al. Risedronate increases bone mass in an early post-menopausal population: Two years of treatment plus one year of follow-up J Clin Endocrinol Metab 83 1998 396-402
43. Chesnut CH III Silverman S Andriano K et al. for the PROOF Study Group A randomized trial of nasal spray calcitonin in postmenopausal women with established osteoporosis: The Prevent Recurrences of Osteoporotic Fractures study Am J Med 109 2000 267-276
44. The WHO Study Group Assessment of Fracture Risk and Its Applications to Screening for Postmenopausal Osteoporosis 1994 World Health Organization Washington, DC
45. Huang C Ross PD Wasnich RD Short-term and long-term fracture prediction by bone mass measurements: A prospective study J Bone Miner Res 13 1998 107-113
46. Johnston CC Jr Epstein S Clinical, biochemical, radiographic, epidemiologic, and economic features of osteoporosis Orthop Clin North Am 12 1981 559-569
47. Genant HK Li J Wu CY Shepherd JA Vertebral fractures in osteoporosis: A new method for clinical assessment J Clin Densitom 3 2000 281-290
48. Genant HK Jergas M Assessment of prevalent and incident vertebral fractures in osteoporosis research Osteoporos Int 14 Suppl 3 2003 S43-S55
49. Drinka PJ DeSmet AA Bauwens SF Rogot A The effect of overlying calcification on lumbar bone densitometry Calcif Tissue Int 50 1992 507-510
50. Rupich RC Griffin MG Pacifici R et al. Lateral dual-energy radiography: Artifact error from rib and pelvic bone J Bone Miner Res 7 1992 97-101
51. Bonnick SL Bone Densitometry in Clinical Practice: Application and Interpretation 2nd ed. Totowa NJ 2004 Humana Press
52. Cheng S Hans D Calcaneal quantitative ultrasound systems - gel coupled. In: Njeh CF Hans D Fuerst T (Eds.) Quantitative Ultrasound 1999 London: Martin Dunitz Ltd 125-144
53. Pluijm SM Graafmans WC Bouter LM Lips P Ultrasound measurements for the prediction of osteoporotic fractures in elderly people Osteoporos Int 9 1999 550-556
54. Kanis JA Johnell O Oden A et al. Ten year probabilities of osteoporotic fractures according to BMD and diagnostic thresholds Osteoporos Int 12 2001 989-995
55. Kleerekoper M The evaluation of the patient with osteoporosis or at risk for osteoporosis. In: Marcus R Feldman D Kelsey J (Eds.) Osteoporosis 2nd ed 2001 San Diego Calif.: Academic Press London 403-408
56. Ovesen L Andersen R Jakobsen J Geographical differences in vitamin D status, with particular reference to European countries Proc Nutr Soc 62 2003 813-821
57. Thomas MK Lloyd-Jones DM Thadhani RM et al. Hypovitaminosis D in medical inpatients N Engl J Med 338 1998 777-783
58. Heaney RP Vitamin D: Role in the calcium economy. In: Feldman D Pike JW Glorieux FH eds. Vitamin D 1997 Academic Press San Diego, Calif 485-497
59. Holick MF McCollum Award Lecture, 1994: Vitamin D - new horizons for the 21st century Am J Clin Nutr 60 1994 619-630
60. Recker RR Hinders S Davies KM et al. Correcting calcium nutritional deficiency prevents spine fractures in elderly women J Bone Miner Res 11 1996 1961-1966
61. Chevalley T Rizzoli R Nyedegger V et al. Effects of calcium supplements on femoral bone mineral density and vertebral fracture rate in vitamin-D-replete elderly patients Osteoporos Int 4 1994 245-252
62. Dawson-Hughes B Harris SS Krall EA Dalla GE Effect of calcium and vitamin D supplementation on bone density in men and women 65 years of age or older N Engl J Med 337 1997 670-676
63. Reid IR Ames RW Evans MC et al. Long-term effects of calcium supplementation on bone loss and fractures in postmenopausal women: A randomized controlled trial Am J Med 98 1995 331-335
64. Heaney RP Age considerations in nutrient needs for bone health: Older adults J Am Coll Nutr 15 1996 575-578
65. Standing Committee on the Scientific Evaluation of Dietary Reference Intakes, Food and Nutrition Board, Institute of Medicine Dietary reference intakes: Calcium, phosphorus, magnesium, vitamin D, and fluoride 1997 National Academies Press San Diego, Calif
66. Bloomfield SA Changes in musculoskeletal structure and function with prolonged bed rest Med Sci Sports Exerc 29 1997 197-206
67. Collet P Uebelhart D Vico L et al. Effects of 1- and 6-month spaceflight on bone mass and biochemistry in two humans Bone 20 1997 547-551
68. Kraemer WJ Adams K Cafarelli E et al. American College of Sports Medicine position stand. Progressive models in resistance training for healthy adults Med Sci Sports Exerc 34 2002 364-380
69. de Jong N Chin A Paw MJ de Groot LC et al. Dietary supplements and physical exercise affecting bone and body composition in frail elderly persons Am J Public Health 90 2000 947-954
70. Tinetti ME McAvay G Claus E Does multiple risk factor reduction explain the reduction in fall rate in the Yale FICSIT Trial? Frailty and Injuries Cooperative Studies of Intervention Techniques Am J Epidemiol 144 1996 389-399
71. Vogt MT Cauley JA Scott JC et al. Smoking and mortality among older women: The Study of Osteoporotic Fractures Arch Intern Med 156 1996 630-636
72. Schapira D Alcohol abuse and osteoporosis Semin Arthritis Rheum 19 1990 371-376
73. Neer RM Arnaud CD Zanchetta JR et al. Effect of parathyroid hormone (1-34) on fractures and bone mineral density in postmenopausal women with osteoporosis N Engl J Med 344 2001 1434-1441
74. Lufkin EG Wahner HW O'Fallon WM et al. Treatment of postmenopausal osteoporosis with transdermal estrogen Ann Intern Med 117 1992 1-9
75. Anderson GL Limacher M Assaf AR et al. Effects of conjugated equine estrogen in post-menopausal women with hysterectomy: The Women's Health Initiative randomized controlled trial JAMA 291 2004 1701-1712
76. Rossouw JE Anderson GI Prentice RL et al. for the Writing Group for the Women's Health Initiative Investigators Risks and benefits of estrogen plus progestin in healthy post-menopausal women: Principal results from the Women's Health Initiative randomized controlled trial JAMA 288 2002 321-333
77. Fletcher SW Colditz GA Failure of estrogen plus progestin therapy for prevention JAMA 288 2002 366-368
78. NIH news release. NHLBI stops trial of estrogen plus progestin due to increased breast cancer risk, lack of overall benefit. Available at: http://www.nhlbi.nih.gov./new/press/02-07-09.htm
79. Nelson HD Humphrey LL Nygren P et al. Postmenopausal hormone replacement therapy: A scientific review JAMA 288 2002 872-881
80. Lindsay R Gallagher JC Kleerekoper M Pickar JH Effect of lower doses of conjugated equine estrogens with and without medroxyprogesterone acetate on bone in early postmenopausal women JAMA 287 2002 2668-2676
81. AHRQ Pub 96-0004 Agency for Health Care Policy and Research, US Dept of Health and Human Services. Health Technology Assessment no. 6: Bone Densitometry: Patients with Asymptomatic Hyperparathyroidism 1995 Rockville, Md.
82. Reginster J Minne HW Sorensen OH et al. for the Vertebral Efficacy with Risedronate Therapy (VERT) Study Group Randomized trial of the effects of risedronate on vertebral fractures in women with established postmenopausal osteoporosis Osteoporos Int 11 2000 83-91
83. Eastell R Barton I Hannon RA et al. Relationship of early changes in bone resorption to the reduction in fracture risk with risedronate J Bone Miner Res 18 2003 1051-1056
84. Chapurlat RD Cummings SR Does follow-up of osteoporotic women treated with antiresorptive therapies improve effectiveness? Osteoporos Int. 13 2002 738-744